Drug and Medication Analysis & Statistics, March 2015 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

571-600 of about 7 500 reports

Purchase Reports From Reputable Market Research Publishers

South America: Castor Oil Seed - Market Report. Analysis And Forecast To 2020

South America: Castor Oil Seed - Market Report. Analysis And Forecast To 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the South American Market of Castor oil seed. It presents the latest data of the market value, consumption, domestic production, exports and imports, price ...

  • Industries : Drug and Medication
  • Countries : South America
Consumer Health in Guatemala

Consumer Health in Guatemala

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

In 2014 consumer health saw healthy retail value growth, growing slightly faster than the growth recorded over 2009-2014 review period. Marketing campaigns, educational campaigns, new product developments ...

  • Industries : Drug and Medication
  • Countries : Guatemala
Consumer Health in Tunisia

Consumer Health in Tunisia

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

Due to the ongoing rapid evolution of the Tunisian pharmaceutical industry, many of the country’s leading manufacturers of consumer health products believe that it is possible to generate further strong ...

  • Industries : Drug and Medication
  • Countries : Tunisia
Consumer Health in Latvia

Consumer Health in Latvia

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

In 2014, consumer health saw strong growth in Latvia due to increasing consumer purchasing power and higher disposable incomes. This changed consumer habits, as many preferred premium products. Furthermore, ...

  • Industries : Drug and Medication
  • Countries : Latvia
Consumer Health in Estonia

Consumer Health in Estonia

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

As Estonian consumers were becoming increasingly confident in economic terms with the country gradually fully recovering from the recession, value sales of consumer health products were seeing positive ...

  • Industries : Drug and Medication
  • Countries : Estonia
Consumer Health in Denmark

Consumer Health in Denmark

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health in Denmark continued to record value growth in current terms in 2014. Even though consumer health products continued to be necessities, safety concerns and a downward price trend in certain ...

  • Industries : Drug and Medication
  • Countries : Denmark
Consumer Health in Venezuela

Consumer Health in Venezuela

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health grew in both volume and current value terms despite the general context of the economic crisis. The industry made efforts to maintain product availability. The Venezuelan government provided ...

  • Industries : Drug and Medication
  • Countries : Venezuela
Consumer Health in Mexico

Consumer Health in Mexico

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

The National Strategy to Prevent and Control Obesity, Weight and Diabetes, announced by the government at the end of 2013, continued the implementation of different actions in 2014. These included: a tax ...

  • Industries : Drug and Medication
  • Countries : Mexico, South Africa, Saudi Arabia
Consumer Health in Greece

Consumer Health in Greece

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health posted positive growth in terms of value sales in 2014, after years of successive declines. The wave of switches that has taken place has expanded the number of products that are classified ...

  • Industries : Drug and Medication
  • Countries : Greece, South Africa, Saudi Arabia
Consumer Health in Canada

Consumer Health in Canada

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

As the growth of older demographics outpaced those of the overall population, the demand for over the counter (OTC) medication and vitamins and dietary supplements (VDS) continued to grow, also supported ...

  • Industries : Drug and Medication
  • Countries : Canada
Consumer Health in Morocco

Consumer Health in Morocco

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

. Euromonitor International's Consumer Health in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, ...

  • Industries : Drug and Medication
  • Countries : Morocco
Consumer Health in Austria

Consumer Health in Austria

  • $ 1 915
  • Industry report
  • March 2015
  • by Euromonitor International

Consumer health saw a stable performance in 2014 compared with the review period. The clear winners in 2014 were digestive remedies, ear care, emergency contraception, eye care and sports nutrition. In ...

  • Industries : Drug and Medication
  • Countries : Austria
Actavis plc - Product Pipeline Review - 2014

Actavis plc - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Actavis plc - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Actavis plc - Product Pipeline Review - 2014’, provides an overview of the Actavis plc’s pharmaceutical research and ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology
  • Countries : United States
SkyePharma PLC - Product Pipeline Review - 2014

SkyePharma PLC - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

SkyePharma PLC - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘SkyePharma PLC - Product Pipeline Review - 2014’, provides an overview of the SkyePharma PLC’s pharmaceutical research ...

  • Industries : Drug and Medication
  • Countries : World
Suda Ltd - Product Pipeline Review - 2014

Suda Ltd - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Suda Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Suda Ltd - Product Pipeline Review - 2014’, provides an overview of the Suda Ltd’s pharmaceutical research and development ...

  • Industries : Drug and Medication, Research and Development, Pharmaceutical
  • Countries : World
Laboratorios SALVAT S.A. - Product Pipeline Review - 2014

Laboratorios SALVAT S.A. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Laboratorios SALVAT S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Laboratorios SALVAT S.A. - Product Pipeline Review - 2014’, provides an overview of the Laboratorios SALVAT ...

  • Industries : Research and Development, Drug and Medication
  • Countries : World, South Korea
Emtricitabine, Tenofovir, Cobicistat, Elvitegravir  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Emtricitabine, Tenofovir, Cobicistat, Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Drug and Medication
Telithromycin  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Telithromycin - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Pathology, Drug and Medication
Key Pharma News 05 JANUARY 2015

Key Pharma News 05 JANUARY 2015

  • $ 1 415
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - AbbVie HCV Approval Places Pressure On Gilead To Change Attitude To Drug Pricing Industry Trend Analysis - Diagnostics Gaining Wider Utility In The Pharmaceutical Market Industry ...

  • Industries : Drug and Medication, Biopharmaceutical
  • Countries : Japan
Epigenetic Therapy in Oncology Drug Pipeline Update 2015

Epigenetic Therapy in Oncology Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

Epigenetic abnormalities are frequent events implicated in the development of many different types of tumors. The first epigenetic modification that was linked to cancer was methylation and to date there ...

  • Industries : Drug and Medication
Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015

Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

Cell adhesion molecules are (glyco)proteins expressed on the cell surface and play a critical role in a wide array of biologic processes that include hemostasis, the immune response, inflammation, embryogenesis, ...

  • Industries : Drug and Medication
Cellular Therapy in Oncology Drug Pipeline Update 2015

Cellular Therapy in Oncology Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

There are today 101 companies plus partners developing 120 cellular therapy drugs in 252 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased ...

  • Industries : Drug and Medication
Cytokine Therapy in Oncology Drug Pipeline Update 2015

Cytokine Therapy in Oncology Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

There are today 81 companies plus partners developing 100 cytokine drugs in 214 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs ove ...

  • Industries : Drug and Medication
Neuroendocrine Tumors Drug Pipeline Update 2015

Neuroendocrine Tumors Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

There are today 85 companies plus partners developing 90 neuroendocrine tumor drugs in 138 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased ...

  • Industries : Drug and Medication
Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2015

Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

The US Food and Drug Administration (FDA) has throughout the last decades added four major ways it can speed up the market approval of new drugs, ranging from Fast track (1988), Accelerated approval (1992), ...

  • Industries : Drug and Medication
IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2015

IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

The IL-1 signaling pathway activates the MAPK/JNK signaling modules. The MAPK pathway leads to activation of NFkB complex. As both IL-1 and TNF alpha stimulate the MAPK signaling module and activate NFkB, ...

  • Industries : Drug and Medication
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2015

IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

The IL-9 signaling pathway activates Jak/STAT and MAPK signaling modules. There are today 65 companies plus partners developing 63 IL-9 pathway targeting drugs in 296 developmental projects in cancer. ...

  • Industries : Drug and Medication
Targeting Tight Junctions in Cancer Drug Pipeline Update 2015

Targeting Tight Junctions in Cancer Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

Epithelial tight junctions (TJs) are composed of at least three types of transmembrane protein -occludin, claudin and junctional adhesion molecules (JAMs)- and a cytoplasmic 'plaque' consisting of many ...

  • Industries : Drug and Medication
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more ...

  • Industries : Drug and Medication
p53 Signaling Pathway in Cancer Drug Pipeline Update 2015

p53 Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 1 499
  • Industry report
  • January 2015
  • by Bioseeker

p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. ...

  • Industries : Drug and Medication

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.